Utah Medical Products SG&A Expenses 2010-2024 | UTMD
Utah Medical Products sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Utah Medical Products Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $13 |
| 2022 | $12 |
| 2021 | $12 |
| 2020 | $11 |
| 2019 | $11 |
| 2018 | $7 |
| 2017 | $7 |
| 2016 | $7 |
| 2015 | $8 |
| 2014 | $8 |
| 2013 | $9 |
| 2012 | $10 |
| 2011 | $10 |
| 2010 | $4 |
| 2009 | $4 |
| Utah Medical Products Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $3 |
| 2023-12-31 | $3 |
| 2023-09-30 | $3 |
| 2023-06-30 | $3 |
| 2023-03-31 | $3 |
| 2022-12-31 | $3 |
| 2022-09-30 | $3 |
| 2022-06-30 | $3 |
| 2022-03-31 | $3 |
| 2021-12-31 | $3 |
| 2021-09-30 | $3 |
| 2021-06-30 | $3 |
| 2021-03-31 | $3 |
| 2020-12-31 | $3 |
| 2020-09-30 | $3 |
| 2020-06-30 | $3 |
| 2020-03-31 | $3 |
| 2019-12-31 | $3 |
| 2019-09-30 | $3 |
| 2019-06-30 | $3 |
| 2019-03-31 | $3 |
| 2018-12-31 | $2 |
| 2018-09-30 | $2 |
| 2018-06-30 | $2 |
| 2018-03-31 | $2 |
| 2017-12-31 | $2 |
| 2017-09-30 | $2 |
| 2017-06-30 | $2 |
| 2017-03-31 | $2 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $2 |
| 2015-12-31 | $2 |
| 2015-09-30 | $2 |
| 2015-06-30 | $2 |
| 2015-03-31 | $2 |
| 2014-12-31 | $2 |
| 2014-09-30 | $2 |
| 2014-06-30 | $2 |
| 2014-03-31 | $2 |
| 2013-12-31 | $2 |
| 2013-09-30 | $2 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | $2 |
| 2012-09-30 | $2 |
| 2012-06-30 | $2 |
| 2012-03-31 | $2 |
| 2011-12-31 | $3 |
| 2011-09-30 | $3 |
| 2011-06-30 | $3 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.240B | $0.050B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $175.233B | 22.94 |
| Stryker (SYK) | United States | $129.957B | 31.13 |
| Boston Scientific (BSX) | United States | $110.003B | 35.04 |
| Medtronic (MDT) | Ireland | $108.204B | 15.64 |
| EssilorLuxottica (ESLOY) | France | $99.874B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $39.398B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 27.83 |
| ResMed (RMD) | United States | $30.257B | 28.41 |
| Koninklijke Philips (PHG) | Netherlands | $25.296B | 19.60 |
| Terumo (TRUMY) | Japan | $25.163B | 35.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.688B | 15.13 |
| Baxter (BAX) | United States | $16.913B | 12.02 |
| Insulet (PODD) | United States | $12.064B | 53.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
| Demant (WILYY) | Denmark | $10.259B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.130B | 26.59 |
| BellRing Brands (BRBR) | United States | $7.607B | 35.78 |
| Lantheus Holdings (LNTH) | United States | $5.529B | 13.78 |
| GN Store Nord (GNNDY) | Denmark | $4.717B | 26.49 |
| Haemonetics (HAE) | United States | $4.448B | 21.98 |
| Perrigo (PRGO) | Ireland | $3.708B | 11.24 |
| Envista Holdings (NVST) | United States | $3.128B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.126B | 14.87 |
| QuidelOrtho (QDEL) | United States | $2.927B | 16.25 |
| Neogen (NEOG) | United States | $2.853B | 27.44 |
| TG Therapeutics (TGTX) | United States | $2.528B | 71.13 |
| ICU Medical (ICUI) | United States | $2.464B | 21.75 |
| Green Thumb Industries (GTBIF) | United States | $2.303B | 45.62 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.250B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.157B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.765B | 51.74 |
| Warby Parker (WRBY) | United States | $1.662B | 0.00 |
| InMode (INMD) | Israel | $1.576B | 8.38 |
| Verano Holdings (VRNOF) | United States | $1.342B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.331B | 9.89 |
| Owens & Minor (OMI) | United States | $1.329B | 11.58 |
| National Vision Holdings (EYE) | United States | $1.113B | 35.42 |
| AtriCure (ATRC) | United States | $1.028B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.994B | 0.00 |
| Evolus (EOLS) | United States | $0.791B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.735B | 15.65 |
| Canopy Growth (CGC) | Canada | $0.714B | 0.00 |
| Quanterix (QTRX) | United States | $0.619B | 0.00 |
| Valneva SE (VALN) | France | $0.619B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.617B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
| Surmodics (SRDX) | United States | $0.600B | 37.59 |
| PetIQ (PETQ) | United States | $0.594B | 19.19 |
| Jin Medical (ZJYL) | China | $0.476B | 0.00 |
| ZimVie (ZIMV) | United States | $0.444B | 37.84 |
| TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
| Biote (BTMD) | United States | $0.417B | 9.60 |
| OraSure Technologies (OSUR) | United States | $0.346B | 11.14 |
| Aurora Cannabis (ACB) | Canada | $0.337B | 0.00 |
| Cerus (CERS) | United States | $0.325B | 0.00 |
| Zynex (ZYXI) | United States | $0.318B | 43.56 |
| Viemed Healthcare (VMD) | United States | $0.273B | 27.00 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| MacroGenics (MGNX) | United States | $0.259B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.241B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.179B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.178B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.153B | 73.30 |
| Veru (VERU) | United States | $0.146B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.08 |
| FitLife Brands (FTLF) | United States | $0.142B | 20.13 |
| Quipt Home Medical (QIPT) | United States | $0.141B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 8.30 |
| Brainsway (BWAY) | Israel | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| MariMed (MRMD) | United States | $0.082B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.043B | 2.83 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Innovative Eyewear (LUCY) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |